dbSNP Short Genetic Variations
Welcome to the Reference SNP (rs) Report
All alleles are reported in the Forward orientation. Click on the Variant Details tab for details on Genomic Placement, Gene, and Amino Acid changes. HGVS names are in the HGVS tab.
Reference SNP (rs) Report
This page reports data for a single dbSNP Reference SNP variation (RefSNP or rs) from the new redesigned dbSNP build.
Top of the page reports a concise summary for the rs, with more specific details included in the corresponding tabs below.
All alleles are reported in the Forward orientation. Use the Genomic View to inspect the nucleotides flanking the variant, and its neighbors.
For more information see Help documentation.
rs1483820164
Current Build 156
Released September 21, 2022
- Organism
- Homo sapiens
- Position
-
chr9:89319783 (GRCh38.p14) Help
The anchor position for this RefSNP. Includes all nucleotides potentially affected by this change, thus it can differ from HGVS, which is right-shifted. See here for details.
- Alleles
- A>G
- Variation Type
- SNV Single Nucleotide Variation
- Frequency
- G=0.000004 (1/251488, GnomAD_exome)
- Clinical Significance
- Not Reported in ClinVar
- Gene : Consequence
- SECISBP2 : Missense Variant
- Publications
- 0 citations
- Genomic View
- See rs on genome
Frequency tab displays a table of the reference and alternate allele frequencies reported by various studies and populations. Table lines, where Population="Global" refer to the entire study population, whereas lines, where Group="Sub", refer to a study-specific population subgroupings (i.e. AFR, CAU, etc.), if available. Frequency for the alternate allele (Alt Allele) is a ratio of samples observed-to-total, where the numerator (observed samples) is the number of chromosomes in the study with the minor allele present (found in "Sample size", where Group="Sub"), and the denominator (total samples) is the total number of all chromosomes in the study for the variant (found in "Sample size", where Group="Study-wide" and Population="Global").
Download| Study | Population | Group | Sample Size | Ref Allele | Alt Allele |
|---|---|---|---|---|---|
| gnomAD - Exomes | Global | Study-wide | 251488 | A=0.999996 | G=0.000004 |
| gnomAD - Exomes | European | Sub | 135410 | A=0.999993 | G=0.000007 |
| gnomAD - Exomes | Asian | Sub | 49010 | A=1.00000 | G=0.00000 |
| gnomAD - Exomes | American | Sub | 34592 | A=1.00000 | G=0.00000 |
| gnomAD - Exomes | African | Sub | 16256 | A=1.00000 | G=0.00000 |
| gnomAD - Exomes | Ashkenazi Jewish | Sub | 10080 | A=1.00000 | G=0.00000 |
| gnomAD - Exomes | Other | Sub | 6140 | A=1.0000 | G=0.0000 |
Variant Details tab shows known variant placements on genomic sequences: chromosomes (NC_), RefSeqGene, pseudogenes or genomic regions (NG_), and in a separate table: on transcripts (NM_) and protein sequences (NP_). The corresponding transcript and protein locations are listed in adjacent lines, along with molecular consequences from Sequence Ontology. When no protein placement is available, only the transcript is listed. Column "Codon[Amino acid]" shows the actual base change in the format of "Reference > Alternate" allele, including the nucleotide codon change in transcripts, and the amino acid change in proteins, respectively, allowing for known ribosomal slippage sites. To view nucleotides adjacent to the variant use the Genomic View at the bottom of the page - zoom into the sequence until the nucleotides around the variant become visible.
| Sequence name | Change |
|---|---|
| GRCh38.p14 chr 9 | NC_000009.12:g.89319783A>G |
| GRCh37.p13 chr 9 | NC_000009.11:g.91934698A>G |
| SECISBP2 RefSeqGene | NG_012177.1:g.6287A>G |
| Molecule type | Change | Amino acid[Codon] | SO Term |
|---|---|---|---|
| SECISBP2 transcript variant 4 | NM_001282690.1:c.-37= | N/A | 5 Prime UTR Variant |
| SECISBP2 transcript variant 8 | NM_001354702.2:c.-680= | N/A | 5 Prime UTR Variant |
| SECISBP2 transcript variant 1 | NM_024077.5:c.168A>G | E [GAA] > E [GAG] | Coding Sequence Variant |
| selenocysteine insertion sequence-binding protein 2 isoform 1 | NP_076982.3:p.Glu56= | E (Glu) > E (Glu) | Synonymous Variant |
| SECISBP2 transcript variant 6 | NM_001354697.2:c.168A>G | E [GAA] > E [GAG] | Coding Sequence Variant |
| selenocysteine insertion sequence-binding protein 2 isoform 6 | NP_001341626.1:p.Glu56= | E (Glu) > E (Glu) | Synonymous Variant |
| SECISBP2 transcript variant 7 | NM_001354698.2:c.168A>G | E [GAA] > E [GAG] | Coding Sequence Variant |
| selenocysteine insertion sequence-binding protein 2 isoform 7 | NP_001341627.1:p.Glu56= | E (Glu) > E (Glu) | Synonymous Variant |
| SECISBP2 transcript variant 3 | NM_001282689.2:c.70A>G | T [ACC] > A [GCC] | Coding Sequence Variant |
| selenocysteine insertion sequence-binding protein 2 isoform 3 | NP_001269618.1:p.Thr24Ala | T (Thr) > A (Ala) | Missense Variant |
| SECISBP2 transcript variant 2 | NM_001282688.2:c.168A>G | E [GAA] > E [GAG] | Coding Sequence Variant |
| selenocysteine insertion sequence-binding protein 2 isoform 2 | NP_001269617.1:p.Glu56= | E (Glu) > E (Glu) | Synonymous Variant |
| SECISBP2 transcript variant 5 | NM_001354696.2:c.168A>G | E [GAA] > E [GAG] | Coding Sequence Variant |
| selenocysteine insertion sequence-binding protein 2 isoform 5 | NP_001341625.1:p.Glu56= | E (Glu) > E (Glu) | Synonymous Variant |
| SECISBP2 transcript variant X1 | XM_011519000.3:c.-37= | N/A | 5 Prime UTR Variant |
| SECISBP2 transcript variant X5 | XM_047423854.1:c.-37= | N/A | 5 Prime UTR Variant |
| SECISBP2 transcript variant X7 | XM_011519001.2:c.-37= | N/A | 5 Prime UTR Variant |
| SECISBP2 transcript variant X9 | XM_011519002.2:c.-37= | N/A | 5 Prime UTR Variant |
| SECISBP2 transcript variant X10 | XM_047423855.1:c.-37= | N/A | 5 Prime UTR Variant |
| SECISBP2 transcript variant X12 | XM_011519003.2:c.-37= | N/A | 5 Prime UTR Variant |
| SECISBP2 transcript variant X18 | XM_047423858.1:c.-37= | N/A | 5 Prime UTR Variant |
| SECISBP2 transcript variant X26 | XM_047423860.1:c.-37= | N/A | 5 Prime UTR Variant |
| SECISBP2 transcript variant X29 | XM_047423862.1:c. | N/A | Genic Upstream Transcript Variant |
| SECISBP2 transcript variant X30 | XM_047423863.1:c. | N/A | Genic Upstream Transcript Variant |
| SECISBP2 transcript variant X13 | XM_047423856.1:c.168A>G | E [GAA] > E [GAG] | Coding Sequence Variant |
| selenocysteine insertion sequence-binding protein 2 isoform X5 | XP_047279812.1:p.Glu56= | E (Glu) > E (Glu) | Synonymous Variant |
| SECISBP2 transcript variant X14 | XM_047423857.1:c.168A>G | E [GAA] > E [GAG] | Coding Sequence Variant |
| selenocysteine insertion sequence-binding protein 2 isoform X5 | XP_047279813.1:p.Glu56= | E (Glu) > E (Glu) | Synonymous Variant |
| SECISBP2 transcript variant X19 | XM_017015122.3:c.168A>G | E [GAA] > E [GAG] | Coding Sequence Variant |
| selenocysteine insertion sequence-binding protein 2 isoform X7 | XP_016870611.1:p.Glu56= | E (Glu) > E (Glu) | Synonymous Variant |
| SECISBP2 transcript variant X22 | XM_047423859.1:c.168A>G | E [GAA] > E [GAG] | Coding Sequence Variant |
| selenocysteine insertion sequence-binding protein 2 isoform X8 | XP_047279815.1:p.Glu56= | E (Glu) > E (Glu) | Synonymous Variant |
| SECISBP2 transcript variant X25 | XM_024447666.2:c.168A>G | E [GAA] > E [GAG] | Coding Sequence Variant |
| selenocysteine insertion sequence-binding protein 2 isoform X9 | XP_024303434.1:p.Glu56= | E (Glu) > E (Glu) | Synonymous Variant |
| SECISBP2 transcript variant X27 | XM_024447667.2:c.70A>G | T [ACC] > A [GCC] | Coding Sequence Variant |
| selenocysteine insertion sequence-binding protein 2 isoform X11 | XP_024303435.1:p.Thr24Ala | T (Thr) > A (Ala) | Missense Variant |
| SECISBP2 transcript variant X28 | XM_047423861.1:c.70A>G | T [ACC] > A [GCC] | Coding Sequence Variant |
| selenocysteine insertion sequence-binding protein 2 isoform X12 | XP_047279817.1:p.Thr24Ala | T (Thr) > A (Ala) | Missense Variant |
| SECISBP2 transcript variant X2 | XR_929840.2:n.349A>G | N/A | Non Coding Transcript Variant |
| SECISBP2 transcript variant X3 | XR_007061345.1:n.349A>G | N/A | Non Coding Transcript Variant |
| SECISBP2 transcript variant X4 | XR_007061346.1:n.349A>G | N/A | Non Coding Transcript Variant |
| SECISBP2 transcript variant X6 | XR_007061347.1:n.349A>G | N/A | Non Coding Transcript Variant |
| SECISBP2 transcript variant X8 | XR_007061348.1:n.349A>G | N/A | Non Coding Transcript Variant |
| SECISBP2 transcript variant X11 | XR_007061349.1:n.349A>G | N/A | Non Coding Transcript Variant |
| SECISBP2 transcript variant X15 | XR_007061350.1:n.245A>G | N/A | Non Coding Transcript Variant |
| SECISBP2 transcript variant X16 | XR_007061351.1:n.245A>G | N/A | Non Coding Transcript Variant |
| SECISBP2 transcript variant X17 | XR_007061352.1:n.245A>G | N/A | Non Coding Transcript Variant |
| SECISBP2 transcript variant X20 | XR_007061353.1:n.245A>G | N/A | Non Coding Transcript Variant |
| SECISBP2 transcript variant X21 | XR_007061354.1:n.245A>G | N/A | Non Coding Transcript Variant |
| SECISBP2 transcript variant X23 | XR_007061355.1:n.349A>G | N/A | Non Coding Transcript Variant |
| SECISBP2 transcript variant X24 | XR_007061356.1:n.349A>G | N/A | Non Coding Transcript Variant |
Clinical Significance tab shows a list of clinical significance entries from ClinVar associated with the variation, per allele. Click on the RCV accession (i.e. RCV000001615.2) or Allele ID (i.e. 12274) to access full ClinVar report.
Aliases tab displays HGVS names representing the variant placements and allele changes on genomic, transcript and protein sequences, per allele. HGVS name is an expression for reporting sequence accession and version, sequence type, position, and allele change. The column "Note" can have two values: "diff" means that there is a difference between the reference allele (variation interval) at the placement reported in HGVS name and the reference alleles reported in other HGVS names, and "rev" means that the sequence of this variation interval at the placement reported in HGVS name is in reverse orientation to the sequence(s) of this variation in other HGVS names not labeled as "rev".
| Placement | A= | G |
|---|---|---|
| GRCh38.p14 chr 9 | NC_000009.12:g.89319783= | NC_000009.12:g.89319783A>G |
| GRCh37.p13 chr 9 | NC_000009.11:g.91934698= | NC_000009.11:g.91934698A>G |
| SECISBP2 RefSeqGene | NG_012177.1:g.6287= | NG_012177.1:g.6287A>G |
| SECISBP2 transcript variant 1 | NM_024077.5:c.168= | NM_024077.5:c.168A>G |
| SECISBP2 transcript variant 1 | NM_024077.4:c.168= | NM_024077.4:c.168A>G |
| SECISBP2 transcript | NM_024077.3:c.168= | NM_024077.3:c.168A>G |
| SECISBP2 transcript variant 2 | NM_001282688.2:c.168= | NM_001282688.2:c.168A>G |
| SECISBP2 transcript variant 2 | NM_001282688.1:c.168= | NM_001282688.1:c.168A>G |
| SECISBP2 transcript variant 8 | NM_001354702.2:c.-680= | NM_001354702.2:c.-680A>G |
| SECISBP2 transcript variant 8 | NM_001354702.1:c.-680= | NM_001354702.1:c.-680A>G |
| SECISBP2 transcript variant 6 | NM_001354697.2:c.168= | NM_001354697.2:c.168A>G |
| SECISBP2 transcript variant 6 | NM_001354697.1:c.168= | NM_001354697.1:c.168A>G |
| SECISBP2 transcript variant 5 | NM_001354696.2:c.168= | NM_001354696.2:c.168A>G |
| SECISBP2 transcript variant 5 | NM_001354696.1:c.168= | NM_001354696.1:c.168A>G |
| SECISBP2 transcript variant 3 | NM_001282689.2:c.70= | NM_001282689.2:c.70A>G |
| SECISBP2 transcript variant 3 | NM_001282689.1:c.70= | NM_001282689.1:c.70A>G |
| SECISBP2 transcript variant 7 | NM_001354698.2:c.168= | NM_001354698.2:c.168A>G |
| SECISBP2 transcript variant 7 | NM_001354698.1:c.168= | NM_001354698.1:c.168A>G |
| SECISBP2 transcript variant 4 | NM_001282690.1:c.-37= | NM_001282690.1:c.-37A>G |
| SECISBP2 transcript variant X1 | XM_011519000.3:c.-37= | XM_011519000.3:c.-37A>G |
| SECISBP2 transcript variant X1 | XM_011519000.2:c.-37= | XM_011519000.2:c.-37A>G |
| SECISBP2 transcript variant X1 | XM_011519000.1:c.-37= | XM_011519000.1:c.-37A>G |
| SECISBP2 transcript variant X19 | XM_017015122.3:c.168= | XM_017015122.3:c.168A>G |
| SECISBP2 transcript variant X6 | XM_017015122.2:c.168= | XM_017015122.2:c.168A>G |
| SECISBP2 transcript variant X6 | XM_017015122.1:c.168= | XM_017015122.1:c.168A>G |
| SECISBP2 transcript variant X2 | XR_929840.2:n.349= | XR_929840.2:n.349A>G |
| SECISBP2 transcript variant X2 | XR_929840.1:n.326= | XR_929840.1:n.326A>G |
| SECISBP2 transcript variant X7 | XM_011519001.2:c.-37= | XM_011519001.2:c.-37A>G |
| SECISBP2 transcript variant X3 | XM_011519001.1:c.-37= | XM_011519001.1:c.-37A>G |
| SECISBP2 transcript variant X9 | XM_011519002.2:c.-37= | XM_011519002.2:c.-37A>G |
| SECISBP2 transcript variant X4 | XM_011519002.1:c.-37= | XM_011519002.1:c.-37A>G |
| SECISBP2 transcript variant X12 | XM_011519003.2:c.-37= | XM_011519003.2:c.-37A>G |
| SECISBP2 transcript variant X5 | XM_011519003.1:c.-37= | XM_011519003.1:c.-37A>G |
| SECISBP2 transcript variant X25 | XM_024447666.2:c.168= | XM_024447666.2:c.168A>G |
| SECISBP2 transcript variant X10 | XM_024447666.1:c.168= | XM_024447666.1:c.168A>G |
| SECISBP2 transcript variant X27 | XM_024447667.2:c.70= | XM_024447667.2:c.70A>G |
| SECISBP2 transcript variant X14 | XM_024447667.1:c.70= | XM_024447667.1:c.70A>G |
| SECISBP2 transcript variant X5 | XM_047423854.1:c.-37= | XM_047423854.1:c.-37A>G |
| SECISBP2 transcript variant X13 | XM_047423856.1:c.168= | XM_047423856.1:c.168A>G |
| SECISBP2 transcript variant X14 | XM_047423857.1:c.168= | XM_047423857.1:c.168A>G |
| SECISBP2 transcript variant X10 | XM_047423855.1:c.-37= | XM_047423855.1:c.-37A>G |
| SECISBP2 transcript variant X22 | XM_047423859.1:c.168= | XM_047423859.1:c.168A>G |
| SECISBP2 transcript variant X6 | XR_007061347.1:n.349= | XR_007061347.1:n.349A>G |
| SECISBP2 transcript variant X4 | XR_007061346.1:n.349= | XR_007061346.1:n.349A>G |
| SECISBP2 transcript variant X15 | XR_007061350.1:n.245= | XR_007061350.1:n.245A>G |
| SECISBP2 transcript variant X3 | XR_007061345.1:n.349= | XR_007061345.1:n.349A>G |
| SECISBP2 transcript variant X8 | XR_007061348.1:n.349= | XR_007061348.1:n.349A>G |
| SECISBP2 transcript variant X16 | XR_007061351.1:n.245= | XR_007061351.1:n.245A>G |
| SECISBP2 transcript variant X17 | XR_007061352.1:n.245= | XR_007061352.1:n.245A>G |
| SECISBP2 transcript variant X11 | XR_007061349.1:n.349= | XR_007061349.1:n.349A>G |
| SECISBP2 transcript variant X20 | XR_007061353.1:n.245= | XR_007061353.1:n.245A>G |
| SECISBP2 transcript variant X21 | XR_007061354.1:n.245= | XR_007061354.1:n.245A>G |
| SECISBP2 transcript variant X18 | XM_047423858.1:c.-37= | XM_047423858.1:c.-37A>G |
| SECISBP2 transcript variant X28 | XM_047423861.1:c.70= | XM_047423861.1:c.70A>G |
| SECISBP2 transcript variant X23 | XR_007061355.1:n.349= | XR_007061355.1:n.349A>G |
| SECISBP2 transcript variant X24 | XR_007061356.1:n.349= | XR_007061356.1:n.349A>G |
| SECISBP2 transcript variant X26 | XM_047423860.1:c.-37= | XM_047423860.1:c.-37A>G |
| selenocysteine insertion sequence-binding protein 2 isoform 1 | NP_076982.3:p.Glu56= | NP_076982.3:p.Glu56= |
| selenocysteine insertion sequence-binding protein 2 isoform 2 | NP_001269617.1:p.Glu56= | NP_001269617.1:p.Glu56= |
| selenocysteine insertion sequence-binding protein 2 isoform 6 | NP_001341626.1:p.Glu56= | NP_001341626.1:p.Glu56= |
| selenocysteine insertion sequence-binding protein 2 isoform 5 | NP_001341625.1:p.Glu56= | NP_001341625.1:p.Glu56= |
| selenocysteine insertion sequence-binding protein 2 isoform 3 | NP_001269618.1:p.Thr24= | NP_001269618.1:p.Thr24Ala |
| selenocysteine insertion sequence-binding protein 2 isoform 7 | NP_001341627.1:p.Glu56= | NP_001341627.1:p.Glu56= |
| selenocysteine insertion sequence-binding protein 2 isoform X7 | XP_016870611.1:p.Glu56= | XP_016870611.1:p.Glu56= |
| selenocysteine insertion sequence-binding protein 2 isoform X9 | XP_024303434.1:p.Glu56= | XP_024303434.1:p.Glu56= |
| selenocysteine insertion sequence-binding protein 2 isoform X11 | XP_024303435.1:p.Thr24= | XP_024303435.1:p.Thr24Ala |
| selenocysteine insertion sequence-binding protein 2 isoform X5 | XP_047279812.1:p.Glu56= | XP_047279812.1:p.Glu56= |
| selenocysteine insertion sequence-binding protein 2 isoform X5 | XP_047279813.1:p.Glu56= | XP_047279813.1:p.Glu56= |
| selenocysteine insertion sequence-binding protein 2 isoform X8 | XP_047279815.1:p.Glu56= | XP_047279815.1:p.Glu56= |
| selenocysteine insertion sequence-binding protein 2 isoform X12 | XP_047279817.1:p.Thr24= | XP_047279817.1:p.Thr24Ala |
| SECISBP2 transcript variant X7 | XM_005252198.1:c.-23+1171= | XM_005252198.1:c.-23+1171A>G |
Submissions tab displays variations originally submitted to dbSNP, now supporting this RefSNP cluster (rs). We display Submitter handle, Submission identifier, Date and Build number, when the submission appeared for the first time. Direct submissions to dbSNP have Submission ID in the form of an ss-prefixed number (ss#). Other supporting variations are listed in the table without ss#.
| No | Submitter | Submission ID | Date (Build) |
|---|---|---|---|
| 1 | GNOMAD | ss2737694430 | Nov 08, 2017 (151) |
| 2 | gnomAD - Exomes | NC_000009.11 - 91934698 | Jul 13, 2019 (153) |
History tab displays RefSNPs (Associated ID) from previous builds (Build) that now support the current RefSNP, and the dates, when the history was updated for each Associated ID (History Updated).
Publications tab displays PubMed articles citing the variation as a listing of PMID, Title, Author, Year, Journal, ordered by Year, descending.
No publications for rs1483820164
The Flanks tab provides retrieving flanking sequences of a SNP on all molecules that have placements.
Genomic regions, transcripts, and products
Top▲
Help
NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.
NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.